The data illustrates key figures on European public biotech companies from 2012 to 2016. In 2016, revenues of European public biotech companies amounted to some 27 billion USD. In the same year, R&D spending stood at nearly seven billion dollars.
Revenues (in billion U.S. dollars) | 20.4 | 20.9 | 24 | 22.8 | 27.2 |
R&D expense (in billion U.S. dollars) | 5 | 4.9 | 5.6 | 6.7 | 6.9 |
Net income (in billion U.S. dollars) | 0.2 | 1.1 | 3.2 | 1 | -1.3 |
Market capitalization | 80.1 | 114.7 | 162.5 | 150.1 | 164.2 |
Number of employees | 52540 | 54440 | 61320 | 48590 | 67460 |